Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Mengxin Zhang is a pioneering pediatric surgeon whose work is reshaping minimally invasive surgical care for children with congenital gastrointestinal disorders. Her research centers on the comparative efficacy and safety of robotic-assisted versus laparoscopic techniques, with a primary focus on three critical conditions: Hirschsprung disease, choledochal cysts, and biliary atresia. In her landmark 2023 study, Dr. Zhang demonstrated that robotic-assisted proctosigmoidectomy offers measurable advantages over laparoscopic-assisted Soave pull-through for Hirschsprung disease, a finding that has already garnered 39 citations and influenced surgical protocols. She further advanced the field with a systematic review and proportional meta-analysis (2022, 21 citations) establishing robotic surgery as a safe, effective alternative to laparoscopy for pediatric choledochal cyst excision. Most notably, Dr. Zhang was among the first to report outcomes for robotic-assisted Kasai portoenterostomy in biliary atresia (2023, 15 citations), a technically demanding procedure where precision is paramount. Her cumulative work—spanning comparative trials, meta-analyses, and novel technique descriptions—provides the evidence base for a paradigm shift toward robotic surgery in pediatric hepatobiliary and colorectal surgery, directly improving recovery times and surgical outcomes for the youngest patients.